Loading
Nanoplatforms for Cancer Theranostics / Photodynamic Therapy Research Studies · Journal article
Acs Applied Bio Materials · September 4, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is an early-stage rational design and synthesis study of thionaphthalimide-based photosensitizers formulated as biocompatible nanoparticles. The work demonstrates favorable photophysical properties (red shift, increased molar absorptivity, improved singlet oxygen yield) and proof-of-concept phototoxicity in HeLa cells under red light, but provides no efficacy data, animal models, or comparative benchmarking against existing agents.
In vitro chemical synthesis and cell-based assay study. HeLa cervical adenocarcinoma cells.. Intervention: MANIH-S nanoparticles formulated with DSPE-PEG(2000)-biotin, exposed to red light irradiation..
Thiocarbonyl substitution in naphthalimide core caused significant red shift in absorption and increased molar absorptivity Thiocarbonyl modification resulted in marked improvement in singlet oxygen generation efficiency MANIH-S nanoparticles generated reactive oxygen species via type I and type II photodynamic mechanisms upon red light irradiation
MANIH-S nanoparticles exhibited strong phototoxic effects against HeLa cells under red light with minimal dark toxicity
The source did not state who this applies to in practice.
Early-phase in vitro study of a novel photosensitizer design with cell-line validation but no in vivo efficacy, animal models, or clinical data.
As stated by the source record.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Heavy-atom-free photosensitizers, particularly those containing thiocarbonyl groups, hold significant promise for photodynamic therapy, yet their full potential remains untapped. The unique photophysical and photochemical properties of sulfur-modified carbonyl fluorophores are not fully understood. Additionally, challenges such as limited aqueous solubility, aggregation-induced quenching, and inadequate tumor-targeting efficiency hinder their effectiveness in biomedical applications. In this study, we designed and synthesized two thionated naphthalimides and evaluated their potential for photodynamic therapy. Our results showed that transforming carbonyl groups into thiocarbonyl moieties within the naphthalimide structure caused a significant red shift in the absorption profile. This modification also resulted in increased molar absorptivity and a marked improvement in singlet oxygen generation efficiency. Interestingly, substituting at the imide nitrogen of the naphthalimide core had little effect on absorption characteristics and singlet oxygen generation. In contrast, replacing the dimethylamino group with a triphenylamine moiety at the para position of the naphthalimide led to a hypsochromic shift in the absorption spectrum, along with lower molar absorptivity and reduced singlet oxygen yield. Additionally, we successfully prepared biocompatible MANIH-S nanoparticles (MANIH-S NPs) by encapsulating MANIH-S in DSPE-PEG(2000)-biotin to enhance the system's biomedical potential. Upon red light irradiation, MANIH-S NPs effectively generated reactive oxygen species via both type I and type II photodynamic mechanisms. Additionally, these nanoparticles exhibited strong phototoxic effects against HeLa cells when exposed to red light while showing minimal toxicity in the dark. This work highlights the potential of sulfur-substituted naphthalimide derivatives, combined with DSPE-PEG(2000)-biotin nanoencapsulation, as a versatile platform for advanced photodynamic cancer therapy.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.